Atropine Eye Drop Market

Atropine sulfate is an antimuscarinic agent used as a cycloplegic and mydriatic. The eye drops are used in the treatment of iritis and uveitis to immobilise the iris and ciliary muscle and to prevent or break down adhesions.

Since it is a powerful cycloplegic it is used in the determination of refraction in children below six years and children with convergent strabismus.

Atropine Eye Drop Market contains market size and forecasts of Atropine Eye Drop in global, including the following market information:

• Global Atropine Eye Drop Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Atropine Eye Drop Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Atropine Eye Drop companies in 2021 (%)

The global Atropine Eye Drop market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.001 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Atropine Eye Drop include Martindale Pharma Ethypharm, Aspire Pharma Ltd, Bausch & Lomb U.K Limited and OSRX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Atropine Eye Drop manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Atropine Eye Drop Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Atropine Eye Drop Market Segment Percentages, by Type, 2021 (%)

• 0.001
• 0.005
• 0.01

Global Atropine Eye Drop Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Atropine Eye Drop Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Ophthalmic Clinic
• Pharmacy
• Others

Global Atropine Eye Drop Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Atropine Eye Drop Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Atropine Eye Drop revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Atropine Eye Drop revenues share in global market, 2021 (%)
• Key companies Atropine Eye Drop sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Atropine Eye Drop sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Martindale Pharma Ethypharm
• Aspire Pharma Ltd
• Bausch & Lomb U.K Limited
• OSRX